🚀 VC round data is live in beta, check it out!

Cyclezyme Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cyclezyme and similar public comparables like EcoRub, XP Chemistries, Trinseo, POLYDUCT Plastic and more.

Cyclezyme Overview

About Cyclezyme

Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.


Founded

N/A

HQ

Sweden

Employees

N/A

Sectors

Financials (FY)

Revenue: $91K
EBITDA: ($162K)

EV

$4M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cyclezyme Financials

Cyclezyme reported last fiscal year revenue of $91K and negative EBITDA of ($162K).

In the same fiscal year, Cyclezyme generated $272K in gross profit, ($162K) in EBITDA losses, and had net loss of ($172K).


Cyclezyme P&L

In the most recent fiscal year, Cyclezyme reported revenue of $91K and EBITDA of ($162K).

Cyclezyme expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cyclezyme forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$91KXXXXXXXXX
Gross ProfitXXX$272KXXXXXXXXX
Gross MarginXXX297%XXXXXXXXX
EBITDAXXX($162K)XXXXXXXXX
EBITDA MarginXXX(177%)XXXXXXXXX
EBIT MarginXXX(183%)XXXXXXXXX
Net ProfitXXX($172K)XXXXXXXXX
Net MarginXXX(188%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Cyclezyme Stock Performance

Cyclezyme has current market cap of $4M, and enterprise value of $4M.

Market Cap Evolution


Cyclezyme's stock price is $1.49.

See Cyclezyme trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4M$4M0.7%XXXXXXXXX$-0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cyclezyme Valuation Multiples

Cyclezyme trades at 39.5x EV/Revenue multiple, and (22.4x) EV/EBITDA.

See valuation multiples for Cyclezyme and 15K+ public comps

Cyclezyme Financial Valuation Multiples

As of April 22, 2026, Cyclezyme has market cap of $4M and EV of $4M.

Equity research analysts estimate Cyclezyme's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cyclezyme has a P/E ratio of (22.5x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$4MXXX$4MXXXXXXXXX
EV (current)$4MXXX$4MXXXXXXXXX
EV/RevenueXXX39.5xXXXXXXXXX
EV/EBITDAXXX(22.4x)XXXXXXXXX
EV/EBITXXX(21.5x)XXXXXXXXX
EV/Gross ProfitXXX13.3xXXXXXXXXX
P/EXXX(22.5x)XXXXXXXXX
EV/FCFXXX(8.2x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cyclezyme Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cyclezyme Margins & Growth Rates

Cyclezyme's revenue in the last fiscal year grew by .

See operational valuation multiples for Cyclezyme and other 15K+ public comps

Cyclezyme Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDA MarginXXX(177%)XXXXXXXXX
EBITDA GrowthXXX(27%)XXXXXXXXX
Opex to RevenueXXX481%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cyclezyme Public Comps

See public comps and valuation multiples for other Chemicals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
CyclezymeXXXXXXXXXXXXXXXXXX
EcoRubXXXXXXXXXXXXXXXXXX
XP ChemistriesXXXXXXXXXXXXXXXXXX
TrinseoXXXXXXXXXXXXXXXXXX
POLYDUCT PlasticXXXXXXXXXXXXXXXXXX
Svenska AerogelXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Cyclezyme M&A Activity

Cyclezyme acquired XXX companies to date.

Last acquisition by Cyclezyme was on XXXXXXXX, XXXXX. Cyclezyme acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Cyclezyme

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Cyclezyme Investment Activity

Cyclezyme invested in XXX companies to date.

Cyclezyme made its latest investment on XXXXXXXX, XXXXX. Cyclezyme invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Cyclezyme

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cyclezyme

Where is Cyclezyme headquartered?Cyclezyme is headquartered in Sweden.
Is Cyclezyme publicly listed?Yes, Cyclezyme is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Cyclezyme?Cyclezyme trades under CYCLE ticker.
When did Cyclezyme go public?Cyclezyme went public in 2023.
Who are competitors of Cyclezyme?Cyclezyme main competitors are EcoRub, XP Chemistries, Trinseo, POLYDUCT Plastic.
What is the current market cap of Cyclezyme?Cyclezyme's current market cap is $4M.
What is the current revenue of Cyclezyme?Cyclezyme's last fiscal year revenue is $91K.
What is the current EV/Revenue multiple of Cyclezyme?Current revenue multiple of Cyclezyme is 39.5x.
Is Cyclezyme profitable?No, Cyclezyme is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial